Capturing fetal heart activity using ECG technology
Can Conventional ECG Technology Capture Fetal Cardiac Activity?
NA · University of Washington · NCT03111173
This study is testing if a special heart monitor can accurately capture a baby's heartbeat in pregnant women who are 32 weeks along or more.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 55 Years |
| Sex | Female |
| Sponsor | University of Washington (other) |
| Locations | 1 site (Seattle, Washington) |
| Trial ID | NCT03111173 on ClinicalTrials.gov |
What this trial studies
This feasibility study aims to determine if a Holter ECG device can effectively capture fetal cardiac activity. Pregnant women between 32 weeks gestation and full term will have both a Holter ECG device and a standard Doppler Fetal Heart Rate (FHR) device attached to their abdomen for a 30-minute recording. The study will compare the data obtained from the Holter device with the standard Doppler FHR readings to validate the algorithm for extracting fetal heart rate from the ECG signals. The procedure will be conducted after routine antepartum testing, ensuring the safety and comfort of the participants.
Who should consider this trial
Good fit: Ideal candidates for this study are singleton or twin pregnant women who are between 32 weeks gestation and full term.
Not a fit: Patients who are in active labor will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this approach could provide a more accurate and non-invasive method for monitoring fetal heart activity.
How similar studies have performed: While this approach is innovative, it is not widely tested, making it a novel exploration in fetal monitoring.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Singleton or twin pregnant women at 32 weeks gestation to full term after routine antepartum testing. Exclusion Criteria: * None.
Where this trial is running
Seattle, Washington
- University of Washington — Seattle, Washington, United States (RECRUITING)
Study contacts
- Principal investigator: Martin G Frasch, MD, PhD — University of Washington
- Study coordinator: Martin G Frasch, MD, PhD
- Email: mfrasch@uw.edu
- Phone: 206-543-5892
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Fetal Monitoring, ECG, Fetus, R peak extraction